Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Zymeworks Inc. (NASDAQ: ZYME)
ZYME Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-37.40%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
62.90%
ZYME Stock Analysis
ZYME
PE Ratio:
ZYME
PEG Ratio:
ZYME
Forward EPS Growth (12 month):
-62.50%
ZYME
PS Ratio:
22
ZYME
PSG Ratio:
-0.7
ZYME
Forward Revenue Growth (12 month):
-29.50%
ZYME Articles
No data was found